Background illustration for clinical trials search

Paid Clinical Trials Alberta

Discover 818 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

for
Systemic Lupus Erythematosus (SLE)
Location: Calgary, West Long Branch NJ, Brooklyn NY, Ottawa,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 16+

Code: NCT07175285

Recruiting

Evaluation of Foreign Body Airway Obstruction Interventions: A Prospective Cohort Study of Adults and Children

for
Choking
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 3+

Code: NCT07814690

Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Bangor ME, Boston MA, Providence RI, Manchester NH,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

Taurine Supplementation in Long COVID

for
Long COVID
Location: Sherbrooke, Montreal, Toronto, Edmonton, Vancouver
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06721949

Phase 2, Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

for
Non-Small Cell Lung Cancer
Location: Boston MA, Mineola NY, New York NY, Philadelphia PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07100080

Phase 2, Phase 3, Recruiting

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for
Atrial Fibrillation
Location: Halifax, Sherbrooke, New York NY, Montreal, Camden NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07217067

Phase 2, Recruiting

Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).

for
Crohn's Disease of Both Small and Large Intestine
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 0 - 70+

Code: NCT07246460

Recruiting

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07175428

Phase 2, Recruiting

Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury

for
Growth Hormone Deficiency, Traumatic Brain Injury
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 70

Code: NCT07795736

Recruiting

Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients

for
Sarcoma, Giant Cell Tumor of Bone
Location: Toronto, Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07227961

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Lake Success NY, New York NY, Philadelphia PA, Ottawa,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase 3, Recruiting

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

for
Non-small Cell Lung Cancer
Location: Westbrook ME, Farmington CT, Stamford CT, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07190248

Phase 3, Recruiting

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

for
Hidradenitis Suppurativa
Location: New York NY, Montreal, Quebec, Miami FL, Charleston SC,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07665437

Phase 3, Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Chicoutimi, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase 2, Phase 3, Recruiting

Wichitasowin: Indigenous Patient Navigator for Young Adults Study

for
Chronic Diseases in Adolescence
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 16 - 25

Code: NCT06443190

Recruiting

Sotatercept in Pulmonary Arterial Hypertension

for
Pulmonary Artery Hypertension
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07140484

Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: London, Kentville, Providence RI, Carmel NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07196722

Phase 2, Phase 3, Recruiting

A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Halifax, New Haven CT, Hackensack NJ, Toronto,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT06988488

Phase 1, Phase 2, Recruiting

Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

for
Severe Asthma
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 55

Code: NCT06705764

Recruiting

Popular cities in Alberta

CalgaryEdmonton